Fig. 2From: Association of interleukin-17A and chemokine/vascular endothelial growth factor-induced angiogenesis in newly diagnosed patients with bladder cancerdemonstrates serum levels of IL-17A (A), and tissue levels of IL-17 A (B), TGF-β (C), and VEGF (D) in patients with BC compared to control. Results are presented as mean ± SD. ****Statistically significant difference between patients with BC and other groups (P ˂ 0.0001)Back to article page